GOVERNEUR, N.Y. – Kinney Drugs has now opened both walk-ins and appointments for a second dose of seasonal COVID-19 vaccine for eligible individuals. In October, the CDC recommended that individuals aged 65 and older and those who are moderately to severely immunocompromised receive a second dose of seasonal COVID-19 vaccine two to six months after their last dose.
Patients in one or both groups who were vaccinated against COVID in the fall may now be due for a second dose. Kinney Drugs accepts walk-ins; however, appointments are encouraged to ensure the promptest service. The COVID-19 vaccine can be co-administered with all other approved vaccines.
“CDC data show the importance of vaccination to protect people who are most at risk for severe outcomes of COVID, such as older adults and anyone with an immunocompromising condition,” said John Marraffa, president of Kinney Drugs. “We know that vaccination can restore and enhance protection against those viruses that are causing infections and hospitalizations in our region, including RSV, COVID, and influenza. And flu is spiking right now, especially in older populations. So, if patients haven’t received their flu vaccine, it’s not too late for this year. As always, our pharmacists stand ready to assist with immunizations and other healthcare needs,” he added.
Kinney Drugs expands COVID-19 vaccine access for high-risk individuals
Patients in one or both groups who were vaccinated against COVID in the fall may now be due for a second dose.
Related
Senate finance leaders introduce bipartisan PBM Reform, NACDS hails move and calls for swift passage
Legislation aims to curtail harmful PBM middlemen tactics that inflate drug costs and force pharmacies to close.
NCPA urges Congress to pass Crapo-Wyden PBM Reforms
Wide bipartisan support means no more excuses, says NCPA.
Walgreens expands micro-fulfillment network with new facility in West Jordan, Utah
The micro-fulfillment center (MFC) will support nearly 96 stores across the region.
CVS Health to pay $37.76 million over insulin pen overbilling allegations
Settlement resolves decade-long False Claims Act violations tied to premature refills and inaccurate reporting to federal health care programs.
Latest
Circana: Fragrance demand expected to rise this holiday season
About one in five consumers purchased fragrance as a holiday gift last year, and purchase intentions are even higher this year.
Americans’ grocery carts score far below health benchmark
The FoodHealth Score assesses purchases based on nutrient density and ingredient quality.
Brian Wynne named chair of American Heart Association's 2026 First Coast Heart Ball
Heart Ball chairmanship centers on advocacy, access, and care for military families.
Facts up Front, SmartLabel gain recognition as transparency efforts grow
According to research from the Consumer Brands Association, 90% of Americans recognize Facts Up Front, and 22 million SmartLabel scans occur each year.